查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1313469

恒溫核酸增幅技術市場：按產品、類型、用途和最終用戶 - 2023-2030 年全球預測

Isothermal Nucleic Acid Amplification Technology Market by Product, Type, Application, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球恒溫核酸增幅技術市場將大幅成長377042萬美元，複合年成長率為13.48%，到2030年將達到驚人的922957萬美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球等恒溫核酸增幅技術市場至關重要。透過檢驗業務策略和產品滿意度等關鍵指標，它可以對供應商進行全面評估，使用戶能夠根據自己的特定需求做出資訊的決策。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.恒溫核酸增幅技術的全球市場規模及預測為何？

2.在預測期內，COVID-19對全球恒溫核酸增幅技術市場的阻礙因素與影響有哪些？

3. 預測期內全球等恒溫核酸增幅技術市場需要投資哪些產品/細分市場/應用/領域？

4.恒溫核酸增幅技術全球市場的競爭策略為何？

5.等恒溫核酸增幅技術全球市場的技術趨勢和法律規範是什麼？

6.全球等恒溫核酸增幅技術市場主要廠商的市佔率為何？

7.恒溫核酸增幅技術適合進入全球市場的型態與策略措施為何？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 世界範圍內，抗菌和感染疾病的流行正在增加。
      • INAAT 的採用率不斷提高，以獲得準確、快速的測試結果
      • 小核酸診斷試劑的研製
    • 抑制因素
      • 試劑和技術實施成本高
    • 機會
      • 恒溫核酸增幅技術進展
      • 數位診斷的採用增加，對即時診斷解決方案的需求增加
    • 任務
      • 恒溫核酸增幅技術的局限性
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 恒溫核酸增幅技術市場：副產品

  • 測定、試劑盒和試劑
  • 系統

第7章 恒溫核酸增幅技術市場：依類型

  • 解旋酶依賴性擴增
  • 環介導等溫擴增
  • 基於核酸序列的擴增
  • 鏈位移的放大
  • 轉錄媒介增幅

第8章 恒溫核酸增幅技術市場：依用途

  • 驗血
  • 感染疾病診斷
    • CT/NG
    • 肝炎
    • HIV
    • 流感

第9章 恒溫核酸增幅技術市場：依最終用戶分類

  • 學術研究所
  • 醫院
  • 參考實驗室

第10章 北美、南美等恒溫核酸增幅技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區等恒溫核酸增幅技術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲等恒溫核酸增幅技術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業
    • 併購
    • 合約、合作和夥伴關係
    • 新產品發布和功能增強
    • 投資、資金籌措

第14章上市公司名單

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-B9334AD6C2F6

The Global Isothermal Nucleic Acid Amplification Technology Market is forecasted to grow significantly, with a projected USD 3,770.42 million in 2023 at a CAGR of 13.48% and expected to reach a staggering USD 9,229.57 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Isothermal Nucleic Acid Amplification Technology Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Isothermal Nucleic Acid Amplification Technology Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Assays, Kits, & Reagents and Systems. The Assays, Kits, & Reagents commanded largest market share of 63.33% in 2022, followed by Systems.

Based on Type, market is studied across Helicase-dependent Amplification, Loop-mediated Isothermal Amplification, Nucleic Acid Sequence-based Amplification, Strand Displacement Amplification, and Transcription-mediated Amplification. The Loop-mediated Isothermal Amplification commanded largest market share of 25.78% in 2022, followed by Nucleic Acid Sequence-based Amplification.

Based on Application, market is studied across Blood Screening and Infectious Disease Diagnosis. The Infectious Disease Diagnosis is further studied across CT/NG, Hepatitis, HIV, and Influenza. The Infectious Disease Diagnosis commanded largest market share of 56.12% in 2022, followed by Blood Screening.

Based on End-User, market is studied across Academic & Research Institutes, Hospitals, and Reference Laboratories. The Reference Laboratories commanded largest market share of 52.23% in 2022, followed by Hospitals.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.33% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Isothermal Nucleic Acid Amplification Technology Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Isothermal Nucleic Acid Amplification Technology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Isothermal Nucleic Acid Amplification Technology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Isothermal Nucleic Acid Amplification Technology Market?

4. What is the competitive strategic window for opportunities in the Global Isothermal Nucleic Acid Amplification Technology Market?

5. What are the technology trends and regulatory frameworks in the Global Isothermal Nucleic Acid Amplification Technology Market?

6. What is the market share of the leading vendors in the Global Isothermal Nucleic Acid Amplification Technology Market?

7. What modes and strategic moves are considered suitable for entering the Global Isothermal Nucleic Acid Amplification Technology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Isothermal Nucleic Acid Amplification Technology Market, by Product, 2022 vs 2030
  • 4.3. Isothermal Nucleic Acid Amplification Technology Market, by Type, 2022 vs 2030
  • 4.4. Isothermal Nucleic Acid Amplification Technology Market, by Application, 2022 vs 2030
  • 4.5. Isothermal Nucleic Acid Amplification Technology Market, by End-User, 2022 vs 2030
  • 4.6. Isothermal Nucleic Acid Amplification Technology Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of antimicrobial and infectious diseases worldwide
      • 5.1.1.2. Increasing adoption of INAAT for accurate & rapid testing results
      • 5.1.1.3. Development of miniaturized nucleic acid-based diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of reagents and implementation of technology
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in isothermal nucleic acid amplification
      • 5.1.3.2. Increasing adoption of digital diagnostics and rising demand for point-of-care diagnostics solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Limitation of isothermal nucleic acid amplification technology
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Isothermal Nucleic Acid Amplification Technology Market, by Product

  • 6.1. Introduction
  • 6.2. Assays, Kits, & Reagents
  • 6.3. Systems

7. Isothermal Nucleic Acid Amplification Technology Market, by Type

  • 7.1. Introduction
  • 7.2. Helicase-dependent Amplification
  • 7.3. Loop-mediated Isothermal Amplification
  • 7.4. Nucleic Acid Sequence-based Amplification
  • 7.5. Strand Displacement Amplification
  • 7.6. Transcription-mediated Amplification

8. Isothermal Nucleic Acid Amplification Technology Market, by Application

  • 8.1. Introduction
  • 8.2. Blood Screening
  • 8.3. Infectious Disease Diagnosis
    • 8.3.1. CT/NG
    • 8.3.2. Hepatitis
    • 8.3.3. HIV
    • 8.3.4. Influenza

9. Isothermal Nucleic Acid Amplification Technology Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals
  • 9.4. Reference Laboratories

10. Americas Isothermal Nucleic Acid Amplification Technology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Merger & Acquisition
      • 13.3.1.1. Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics
      • 13.3.1.2. Medix Biochemica Acquires German MDx Raw Materials Producer MyPols Biotec
    • 13.3.2. Agreement, Collaboration, & Partnership
      • 13.3.2.1. Stilla Technologies and Atila BioSystems to Co-Develop High-Plex Digital PCR Kits for Oncology
      • 13.3.2.2. Sherlock Biosciences and Tolo Biotech Expand Collaboration to Advance Development and Adoption of CRISPR-based Diagnostics
      • 13.3.2.3. WeTrade and Jiqing Biomedical partner to sell monkeypox tests
    • 13.3.3. New Product Launch & Enhancement
      • 13.3.3.1. Recombinase Polymerase Amplification, or RPA, is the breakthrough, isothermal replacement to PCR
      • 13.3.3.2. Mawi iSWAB Microbiome-EL Enables Prime Discoveries' Development of Rapid Extraction-Less COVID Diagnostic Assay
      • 13.3.3.3. Thermo Fisher introduces two RT-LAMP tests to detect viral pathogens
    • 13.3.4. Investment & Funding
      • 13.3.4.1. Polish biotech Genomtec raises EUR 2.9 million (USD 3.19 million) from share issue
      • 13.3.4.2. Ankur Capital invests in molecular diagnostic startup D-NOME

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 6. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 8. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET DYNAMICS
  • FIGURE 10. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HELICASE-DEPENDENT AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP-MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TRANSCRIPTION-MEDIATED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 16. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY CT/NG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HIV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 235. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 236. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET LICENSE & PRICING